摘要 |
The invention relates to novel betulinic acid derivatives of formula (I), wherein R is C (=CH<SUB>2</SUB>) CH<SUB>3</SUB> or CH(CH<SUB>3</SUB>) <SUB>2</SUB>; R<SUB>2</SUB> together with the adjacent carbonyl group forms a carboxylic acid, carboxylic acid ester or amide or substituted amide; R<SUB>3</SUB> or R<SUB>4</SUB> are hydrogen or aryl with the proviso that both are not independently hydrogen or alkyl or R<SUB>3</SUB> and R<SUB>4</SUB> are combined together to form an aryl ring optionally substituted with a group X, wherein X is selected from halogen, alkyl, cyano, nitro, alkoxy, amino or substituted amine; Y is N or O; and R<SUB>1</SUB> is zero when Y is O, and R<SUB>1</SUB> is hydrogen, alkyl or aryl alkyl when Y is N, useful for inhibition of tumor cancer cells. Formula (I) |
申请人 |
DABUR PHARMA LIMITED;MUKHERJEE, RAMA;SRIVASTAVA, SANJAY, KUMAR;SIDDIQUI, MOHAMMAD, JAMSHED, AHMED;JAGGI, MANU;SINGH, ANU, T.;VARDHAN, ANAND;SINGH, MANOJ, KUMAR;RAJENDRAN, PRAVEEN;JAJOO, HEMANT, KUMAR;BURMAN, ANAND, C.;KUMAR, VIVEK;RANI, NIDHI;AGARWAL, SHIV, KUMAR |
发明人 |
MUKHERJEE, RAMA;SRIVASTAVA, SANJAY, KUMAR;SIDDIQUI, MOHAMMAD, JAMSHED, AHMED;JAGGI, MANU;SINGH, ANU, T.;VARDHAN, ANAND;SINGH, MANOJ, KUMAR;RAJENDRAN, PRAVEEN;JAJOO, HEMANT, KUMAR;BURMAN, ANAND, C.;KUMAR, VIVEK;RANI, NIDHI;AGARWAL, SHIV, KUMAR |